Guided Therapeutics Short Interest Falls 92.7%
July short interest fell sharply for Guided Therapeutics, Prio, and Q.E.P. Co., with each showing multi-fold declines from the prior month, while Obra Opportunistic Structured Products ETF experienced a substantial rise in short interest. Guided Therapeutics saw its short interest drop by 92.7% to 1,437 shares as of mid-July, and its stock traded around $0.25 amid light volume. Prio also posted a large July decline in short interest, down 95.3% to 260 shares, as the stock traded near its 52-week range and a Zacks upgrade to hold was noted. Q.E.P. Co. reported a dramatic 99.6% reduction in short interest to 2 shares, with earnings and revenue disclosed for the quarter. In contrast, Obra’s short interest surged by 1,396.7% to 4,056 shares, though the ETF’s price remained flat around $10.13, highlighting divergent investor sentiment across equities and fixed-income-focused funds.
- Jul 25, 2026FDIG short interest surges 54,816% in July while GIAX, SFRGY and GLFGF also post sharp increases in bearish bets.
- Jul 25, 2026The Obra Opportunistic Structured Products ETF's short interest jumps 1,396.7% amid mixed shifts across small-cap names.
- Jul 25, 2026Guided Therapeutics, Prio S.A. and Q.E.P. Co. see short interest plunge 92.7%, 95.3% and 99.6% respectively in July 2026.
How it spread
Claim check
What each side asserts, disputes — or leaves out entirely.
Analyzing the coverage…
Where do you land?
Whose framing of this story rings truest to you?
Coverage
themarketsdaily.comOtherAB International Low Volatility Equity ETF (NYSEARCA:ILOW) Short Interest Down 88.7% in July
tradingview.comOtherPrice to sales forward of Spark I Acquisition Corp. – NASDAQ:SPKLW – TradingView
watchlistnews.comOtherInvesco S&P 500 Equal Weight Consumer Discretionary ETF (NYSEARCA:RSPD) Sees Significant Growth in Short Interest
